FC
BSX icon

Forte Capital’s Boston Scientific BSX Stock Holding History

Forte Capital’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		$721K Buy
6,714
+425
+7% +$43K 0.08% 148
2025
Q1 		$634K Buy
6,289
+23
+0.4% +$2.32K 0.08% 153
2024
Q4 		$560K Buy
6,266
+158
+3% +$13.9K 0.06% 157
2024
Q3 		$512K Buy
6,108
+255
+4% +$20.1K 0.06% 165
2024
Q2 		$451K Buy
5,853
+570
+11% +$41.7K 0.05% 165
2024
Q1 		$362K Buy
+5,283
New +$340K 0.04% 180

Other funds holding BSX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Forte Capital's BSX Position: Q2 2025 in Review

Forte Capital increased its Boston Scientific (BSX) stake by 6.8% in Q2 2025, buying an estimated $43K and bringing the position to 6,714 shares worth $721K. The position accounts for 0.08% of the portfolio, ranked #148.

Forte Capital first reported a position in BSX in Q1 2024 and has held it in 6 quarters since. 1,693 funds tracked by Wall St. Rank hold BSX as of Q2 2025.

  • Forte Capital held 6,714 shares of Boston Scientific worth $721K as of Q2 2025.
  • Forte Capital bought 425 Boston Scientific shares in Q2 2025, an estimated $43K.
  • Boston Scientific made up 0.08% of Forte Capital's portfolio in Q2 2025, its #148 holding.
  • Forte Capital first reported a position in Boston Scientific in Q1 2024 and has held it in 6 quarters since.
  • 1,693 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2025.

Based on Forte Capital's 13F filing for Q2 2025, filed 15 Jul 2025.